NovoCure Chairman William Doyle's 2020 pay jumps 90% to $16M

NovoCure reports 2020 executive compensation

By ExecPay News

Published: April 27, 2021

NovoCure reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, six NovoCure executives received on average a compensation package of $7.7M, a 36% increase compared to previous year.
Average pay of disclosed executives at NovoCure
William F. Doyle, Chairman, received $16M in total, which increased by 90% compared to 2019. 88% of Doyle's compensation, or $14M, was in stock awards. Doyle also received $1.1M in non-equity incentive plan, $773K in salary, as well as $4.5K in other compensation.
Asaf Danziger, Chief Executive Officer, received a compensation package of $9M, which increased by 22% compared to previous year. 78% of the compensation package, or $6.9M, was in stock awards.
Wilhelmus Groenhuysen, Chief Operating Officer, earned $6.9M in 2020, a 66% increase compared to previous year.
Pritesh Shah, Chief Commercial Officer, received $5.9M in 2020, which increases by 64% compared to 2019.
Todd Longsworth, General Counsel, earned $5.1M in 2020.
Ashley Cordova, Chief Financial Officer, received $3.2M in 2020.

Related executives

William Doyle

NovoCure

Chairman

Asaf Danziger

NovoCure

Chief Executive Officer

Wilhelmus Groenhuysen

NovoCure

Chief Operating Officer

Ashley Cordova

NovoCure

Chief Financial Officer

Pritesh Shah

NovoCure

Chief Commercial Officer

Todd Longsworth

NovoCure

General Counsel

You may also like

Source: SEC filing on April 27, 2021.